Search

Displaying all 4 results
DrugBest match

Darbepoetin alfa

go.drugbank.com/drugs/DB00012
ApprovedInvestigational

Human erythropoietin with 2 aa substitutions to enhance glycosylation (5 N-linked chains), 165 residues (MW=37 kD). Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.

  1. Drug

    Vadadustat

    go.drugbank.com/drugs/DB12255
    ApprovedInvestigational

    [A244165] Vadadustat is an orally administered inhibitor of HIF-PH with a safety and efficacy profile non-inferior to [darbepoetin alfa] for the treatment of anemia in patients with CKD undergoing dialysis … alfa], to counter the decrease in endogenous EPO production.

  2. Drug

    Luspatercept

    go.drugbank.com/drugs/DB12281
    ApprovedInvestigational

    [L42455] Luspatercept is novel in that it ameliorates anemia via action on late-stage erythropoiesis, in contrast to typical erythropoiesis-stimulating agents (ESAs), such as [darbepoetin alfa] and [epoetin … alfa], which act only on early-stage erythropoiesis.

  3. Indication

    Anemia

    go.drugbank.com/conditions/DBCOND0020261
    Drugs: Cyanocobalamin · Daprodustat · Darbepoetin alfa · Epoetin delta · Erythropoietin · Ferrous sulfate anhydrous +10 more